Viemed Healthcare (VMD) Change in Account Payables (2018 - 2026)
Viemed Healthcare (VMD) posted Change in Account Payables of $1.6 million for Q1 2026, up 649.31% on a QoQ basis from -$288000.0 in Q4 2025, and up 34.52% year-over-year from $1.2 million in Q1 2025.
Viemed Healthcare (VMD) Change in Account Payables (2018 - 2026) Analysis & Trends
Viemed Healthcare's Change in Account Payables history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Change in Account Payables rose 34.52% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $885000.0 (down 6.55% YoY) and the FY2025 annual result came in at $479000.0, up 33.43% from the prior year.
- Change in Account Payables was $1.6 million for Q1 2026 at Viemed Healthcare, up from -$288000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.6 million in Q1 2026 and bottomed at -$1.1 million in Q2 2023.
- A 5-year average of $73117.6 and a median of $224000.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables soared 394.74% — and 2023, when it tumbled 604.02%.
- Viemed Healthcare's Change in Account Payables stood at -$351000.0 in 2022, then sank by 72.08% to -$604000.0 in 2023, then jumped by 35.76% to -$388000.0 in 2024, then gained by 25.77% to -$288000.0 in 2025, then soared by 649.31% to $1.6 million in 2026.
- Business Quant data shows VMD's Change in Account Payables at $1.6 million in Q1 2026, -$288000.0 in Q4 2025, and -$831000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | Viemed Healthcare | 459.22 Mn | 449.46 Mn | 42.83 Mn | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | -288,000.00 |
| Dec 31, 2025 | -288,000.00 |
| Sep 30, 2025 | -831,000.00 |
| Sep 30, 2025 | -831,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Mar 31, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | -388,000.00 |
| Dec 31, 2024 | -388,000.00 |
| Sep 30, 2024 | -367,000.00 |
| Sep 30, 2024 | -367,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Dec 31, 2023 | -604,000.00 |
| Dec 31, 2023 | -604,000.00 |